Prostate Cancer Outcomes Associated With Clinical Depression

Share this content:

the Cancer Therapy Advisor take:

Clinically depressed prostate cancer patients received definitive treatment less often and had worse survival as compared with patients without depression, data from a large cohort showed. Prasad, MD, of the Medical University of South Carolina in Charleston, and colleagues queried the Surveillance, Epidemiology and End Results database for 2004 to 2007.

According to a study published online in the Journal of Clinical Oncology, patients with prostate cancer who were diagnosed with clinical depression received definitive treatment less often than their counterparts without clinical depression. Clinically depressed patients with prostate cancer were also found to have poorer survival. 

 

Sandip M. Prasad, MD, and researchers found that the mortality risk for these men was twice as much compared to patients without depression. Researchers studied this relationship by turning to the Surveillance, Epidemiology and End Results (SEER) database for 2004 to 2007. 

 

The researchers analyzed 41,275 patients that had newly diagnosed prostate cancer and found that 1,894 patients had a depressive disorder in the 2-year period before their cancer diagnosis. Through their analysis, researchers found that the patients with a depressive disorder were more likely to be older, unmarried, white, or Hispanic; lived in nonmetropolitan areas with a lower median income; and showed signs of increased comorbidities. 

 

In addition, this subgroup was more likely to enter expectant management, also called watchful waiting, instead of definitive treatment, such as radiotherapy or radical prostatectomy. The researchers said these findings warrant further study because both prostate cancer and clinical depression are relatively common for men living in the United States.

Depression Treatment Underutilized in Head and Neck Cancer Survivors
Prostate Cancer Outcomes Associated With Clinical Depression

Clinically depressed prostate cancer patients received definitive treatment less often and had worse survival as compared with patients without depression, data from a large cohort showed. Prasad, MD, of the Medical University of South Carolina in Charleston, and colleagues queried the Surveillance, Epidemiology and End Results database for 2004 to 2007.

READ FULL ARTICLE From Medical Page Today

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs